TopgOptions

AYTU All Time Low | Fast Track Designation form FDA today

Long
NASDAQ:AYTU   Aytu BioPharma, Inc.
AYTU Aytu BioPharma announced today that the FDA has granted Fast Track designation to AR101, a protein kinase inhibitor, for the treatment of patients with Vascular Ehlers-Danlos Syndrome.

After the bullish news, AYTU stock hit the all time low level.
52 Week Range 0.76 - 7.20
LADENBURG THALM has a price target of $14.50 for the stock.

I think a reversal is imminent.
My price target is $5.25.

Looking forward to read your opinion about it.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.